MedPath

Cefaclor

CEFACLOR EXTENDED-RELEASE TABLETS USPRx only

Approved
Approval ID

0878bdc2-0410-4938-9890-96523aa81c2f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 31, 2019

Manufacturers
FDA

Teva Pharmaceuticals USA, Inc.

DUNS: 001627975

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefaclor

PRODUCT DETAILS

NDC Product Code0093-1087
Application NumberANDA065058
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 31, 2019
Generic NameCefaclor

INGREDIENTS (11)

ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT
CEFACLORActive
Quantity: 500 mg in 1 1
Code: 69K7K19H4L
Classification: ACTIM
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
HYPROMELLOSE 2208 (100 MPA.S)Inactive
Code: B1QE5P712K
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
INDIGOTINDISULFONATE SODIUMInactive
Code: D3741U8K7L
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefaclor - FDA Drug Approval Details